Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262015
Status:
UNKNOWN
Last Update Posted:
2005-12-06
First Post:
2005-12-02
Brief Title:
Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine
Sponsor:
Chiron Corporation
Organization:
Chiron Corporation
Study Overview
Official Title:
A Phase IV Single Center Open-Label Controlled Randomized Study to Evaluate the Memory Response of Children Previously Vaccinated With Chiron Meningococcal C Conjugate Vaccine Menjugate and Describe the Kinetic of the Antibody Response and Maturation on Days 2-7 and 28 After Challenge With Pasteur Merieux Meningococcal AC Polysaccharide Vaccine or Menjugate
Status:
UNKNOWN
Status Verified Date:
2005-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine when a memory immune response after re-vaccination with Meningococcal C conjugate vaccine Menjugate or challenge with Meningococcal AC polysaccharide vaccine can be observed after initial vaccination with Meningococcal C conjugate vaccine during the UK immunization campaign
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None